GRK-biased adrenergic agonists for the treatment of type 2 diabetes and obesity.

Motso A, Pelcman B, Kalinovich A, Kahlous NA, Bokhari MH, Dehvari N, Halleskog C, Waara E, de Jong J, Cheesman E, Kallenberg C, Yakala GK, Murad P, Wetterdal E, Andersson P, van Beek S, Sandström A, Alleluia DN, Talamonti E, Youhanna S, Sabatier P, Koenig C, Willems S, Kemas AM, Hutchinson DS, Ham S, Grätz L, Voss J, Marchan-Alvarez JG, Priede M, Jaunsleine K, Spura J, Kovada V, Supe L, Stoddart LA, Holliday ND, Newton PT, Pillon NJ, Schulte G, Summers RJ, Mutule I, Suna E, Olsen JV, Molenaar P, Carlsson J, Lauschke VM, Wright SC, Bengtsson T

Open source

DOI: 10.1016/j.cell.2025.05.042
Published: 2025 Sep 18
Container: Cell
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.cell.2025.05.042,
  title = {GRK-biased adrenergic agonists for the treatment of type 2 diabetes and obesity.},
  author = {Motso A and Pelcman B and Kalinovich A and Kahlous NA and Bokhari MH and Dehvari N and Halleskog C and Waara E and de Jong J and Cheesman E and Kallenberg C and Yakala GK and Murad P and Wetterdal E and Andersson P and van Beek S and Sandström A and Alleluia DN and Talamonti E and Youhanna S and Sabatier P and Koenig C and Willems S and Kemas AM and Hutchinson DS and Ham S and Grätz L and Voss J and Marchan-Alvarez JG and Priede M and Jaunsleine K and Spura J and Kovada V and Supe L and Stoddart LA and Holliday ND and Newton PT and Pillon NJ and Schulte G and Summers RJ and Mutule I and Suna E and Olsen JV and Molenaar P and Carlsson J and Lauschke VM and Wright SC and Bengtsson T},
  year = {2025},
  journal = {Cell},
  doi = {10.1016/j.cell.2025.05.042},
  url = {https://doi.org/10.1016/j.cell.2025.05.042}
}

RIS

TY  - JOUR
TI  - GRK-biased adrenergic agonists for the treatment of type 2 diabetes and obesity.
AU  - Motso A
AU  - Pelcman B
AU  - Kalinovich A
AU  - Kahlous NA
AU  - Bokhari MH
AU  - Dehvari N
AU  - Halleskog C
AU  - Waara E
AU  - de Jong J
AU  - Cheesman E
AU  - Kallenberg C
AU  - Yakala GK
AU  - Murad P
AU  - Wetterdal E
AU  - Andersson P
AU  - van Beek S
AU  - Sandström A
AU  - Alleluia DN
AU  - Talamonti E
AU  - Youhanna S
AU  - Sabatier P
AU  - Koenig C
AU  - Willems S
AU  - Kemas AM
AU  - Hutchinson DS
AU  - Ham S
AU  - Grätz L
AU  - Voss J
AU  - Marchan-Alvarez JG
AU  - Priede M
AU  - Jaunsleine K
AU  - Spura J
AU  - Kovada V
AU  - Supe L
AU  - Stoddart LA
AU  - Holliday ND
AU  - Newton PT
AU  - Pillon NJ
AU  - Schulte G
AU  - Summers RJ
AU  - Mutule I
AU  - Suna E
AU  - Olsen JV
AU  - Molenaar P
AU  - Carlsson J
AU  - Lauschke VM
AU  - Wright SC
AU  - Bengtsson T
PY  - 2025
JO  - Cell
DO  - 10.1016/j.cell.2025.05.042
UR  - https://doi.org/10.1016/j.cell.2025.05.042
ER  -

APA

A, M., B, P., A, K., NA, K., MH, B., N, D., C, H., E, W., J, D. J., E, C., C, K., GK, Y., P, M., E, W., P, A., S, V. B., A, S., DN, A., E, T., S, Y., P, S., C, K., S, W., AM, K., DS, H., S, H., L, G., J, V., JG, M., M, P., K, J., J, S., V, K., L, S., LA, S., ND, H., PT, N., NJ, P., G, S., RJ, S., I, M., E, S., JV, O., P, M., J, C., VM, L., SC, W., & T, B. (2025). GRK-biased adrenergic agonists for the treatment of type 2 diabetes and obesity.. Cell. https://doi.org/10.1016/j.cell.2025.05.042

Source records

pubmed · retrieved 2026-09-25T20:39:13.231Z
europe-pmc · retrieved 2026-09-25T20:39:13.250Z